AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19432292
Drug: Hospital treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital treatment days
Trial: 19432292
Drug: Oral antidiabetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antidiabetic drug sales
Trial: 1812773
Drug: Antihistamines
RxNorm normalized name: ANTIHISTAMINES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihistamines
Trial: 8191660
Drug: He‐Ne laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: He‐Ne laser treatment (wavelength 0.63 microns, light spot diameter 5 mm, energy 2 mWt, session duration 240 sec, 10 sessions)
Trial: 3321890
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration solution with powdered rice and Dal moong
Trial: 3321890
Drug: Standard WHO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard WHO oral rehydration salt solution (ORS)
Trial: 27012873
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g oral glucose
Trial: 25912695
Drug: Apixaban (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apixaban (10 mg twice daily for 7 days, followed by 5 mg twice daily for 23 weeks)
Trial: 25912695
Drug: UFH/warfarin (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH/warfarin (control treatment)
Trial: 25717286
Drug: UFH/warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH/warfarin
Trial: 25912695
Drug: Apixaban and
RxNorm normalized name: Apixaban
DrugBank: Apixaban (DB06605)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Apixaban and UFH/warfarin
Trial: 17998493
Drug: Trimethoprim-sulfamethoxazole, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole, 1 double-strength tablet twice daily for 3 days
Trial: 17998493
Drug: Nitrofurantoin, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin, 100 mg twice daily for 5 days
Trial: 2508287
Drug: Transcutaneous nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous nitroglycerin patches
Trial: 21429719
Drug: n-3 long
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 long chain polyunsaturated fatty acids (3.7 g/d providing 1.7 g/d EPA and 1.2 g/d DHA)
Trial: 21151623
Drug: Tramadol SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol SR 200 mg tablet (test product)
Trial: 21151623
Drug: Reference product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference product (tramadol SR 200 mg tablet)
Trial: 12411225
Drug: Atomoxetine (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (once daily for 6 weeks)
Trial: 12411225
Drug: Placebo (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (once daily for 6 weeks)
Trial: 7898297
Drug: Neutrally-framed information
RxNorm normalized name: PCxx Neutral Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutrally-framed information about chemotherapeutic treatment
Trial: 7898297
Drug: Positively-framed information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positively-framed information about chemotherapeutic treatment
Trial: 7898297
Drug: Negatively-framed information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negatively-framed information about chemotherapeutic treatment
Trial: 212171
Drug: Prophylactic brain
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic brain irradiation (low doses)
Trial: 24517948
Drug: Patient-controlled intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled intravenous analgesia (PCA)
Trial: 28810442
Drug: Internet‐administered cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet‐administered cognitive behavioral treatment
Trial: 25106547
Drug: Thyme honey
RxNorm normalized name: THYME
DrugBank: Thyme (DB10983)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyme honey nasal spray
Trial: 19473635
Drug: Oral falecalcitriol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral falecalcitriol
Trial: 15209198
Drug: Saline flush
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline flush during vasectomy (10 mL normal saline)
Trial: 12452382
Drug: Rectal distension
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal distension inducing an urgency for defecation (average volume of air: 72.5 ml)
Trial: 12452382
Drug: Control session
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control session (20 ml of air in rectal balloon)
Trial: 12452382
Drug: Rectal distension
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal distension inducing an urgency for defecation
Trial: 12452382
Drug: Both sessions
RxNorm normalized name: Alternanthera sessilis extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both sessions (rectal distension and control)
Trial: 9690724
Drug: Omeprazole (5-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (5-day administration)
Trial: 2732142
Drug: FCE 22101
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FCE 22101 (1 g dose, intravenous bolus) after 750 ml water (treatment A)
Trial: 2732142
Drug: FCE 22101
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FCE 22101 (1 g dose, intravenous bolus) after 8 h of water restriction (treatment B)
Trial: 2732142
Drug: Placebo under
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo under water restriction (treatment C)
Trial: 27209586
Drug: CHF 5993
RxNorm normalized name: CHF 4227
DrugBank: CHF 4227 (DB05882)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF 5993 with cimetidine (800 mg twice daily for 6 days)
Trial: 9028089
Drug: Amrinone (3-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amrinone (3-5 mg.kg-1.min-1) combined with dopamine (3-5 mg.kg-1.min-1)
Trial: 9028089
Drug: Nitroglycerin (0.3-1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (0.3-1.0 mg.kg-1.min-1) combined with dopamine (3-5 mg.kg-1.min-1)
Trial: 8500234
Drug: Optimal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal therapy in patients < 75 years old
Trial: 2952156
Drug: Topical clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical clindamycin phosphate 1%
Trial: 6242074
Drug: Oral tetracycline
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tetracycline
Trial: 29110281
Drug: weight-loss intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: weight-loss intervention + 50,000 IU/week oral vitamin D3
Trial: 24703512
Drug: Sham ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham ultrasound therapy (SUST)
Trial: 19865092
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg atorvastatin daily for 12 weeks
Trial: 18262390
Drug: High-fat test
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat test meal (59 +/- 4 g fat; 71% of energy as fat) with high saturated:unsaturated fatty acids ratio (approximately 71:29)
Trial: 18262390
Drug: High-fat test
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat test meal (59 +/- 4 g fat; 71% of energy as fat) with low saturated:unsaturated fatty acids ratio (approximately 55:45)
Trial: 12663284
Drug: L-amino acid
RxNorm normalized name: L-α-amino-γ-methylmercaptobutyric acid
DrugBank: Methionine (DB00134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-amino acid diet supplying either 14 and 30 mg leucine x kg(‐1)x d(‐1) or 22 and 40 mg leucine x kg(‐1)x d(‐1)
Trial: 12663284
Drug: [2H3]leucine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [2H3]leucine administered orally at an intake of 40 mg x kg(‐1) x d(‐1)
Trial: 10638903
Drug: Vecuronium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium infusion at 5 microg x kg(‐1) x min(‐1) until the first response of each train‐of‐four had decreased by 70%.
Trial: 10638903
Drug: Vecuronium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium infusion at 20 microg x kg(‐1) x min(‐1) for 10 min.
Trial: 6529613
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg xipamide
Trial: 6529613
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg xipamide
Trial: 6529613
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg xipamide
Trial: 20337866
Drug: 16 mL
RxNorm normalized name: 16 ML Mvasi 25 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mL tea
Trial: 20337866
Drug: 25 mL
RxNorm normalized name: ethanol 6.025 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mL tea
Trial: 20337866
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL tea
Trial: 17502874
Drug: Lean fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lean fish (3 x 150 g portions of cod/week)
Trial: 17502874
Drug: Fatty fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fatty fish (3 x 150 g portions of salmon/week)
Trial: 18420395
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (DHA+EPA capsules, no seafood)
Trial: 17502874
Drug: Control (sunflower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (sunflower oil capsules, no seafood)
Trial: 12852722
Drug: Strict fasting
RxNorm normalized name: Euphrasia stricta extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strict fasting capillary glucose target level (< 6.5 mmol/l)
Trial: 12852722
Drug: Less strict
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less strict fasting capillary glucose target level (< 8.5 mmol/l)
Trial: 19650825
Drug: AZD9343 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD9343 320 mg
Trial: 11966493
Drug: Baclofen 40
RxNorm normalized name: baclofen 40,000 MCG per 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen 40 mg
Trial: 17239705
Drug: Istaroxime at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Istaroxime at doses >or=1 micro/kg per min
Trial: 17239705
Drug: Istaroxime at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Istaroxime at doses of 0.5 micro/kg per min
Trial: 15150183
Drug: Piperacillin-tazobactam 3.375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin-tazobactam 3.375 g every 6 h
Trial: 14642996
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) at a mean dose of 2053 mg/day for a duration of 125 days
Trial: 10442205
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg tramadol
Trial: 7851201
Drug: Bran (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bran (20 g/24 hr)
Trial: 25257210
Drug: Oxygen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen therapy alone
Trial: 15521899
Drug: low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: low dose salbutamol via pMDI + Volumatic
Trial: 15521899
Drug: high dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: high dose salbutamol via Diskus
Trial: 11134196
Drug: Prednisone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (5 mg orally, four times a day)
Trial: 11134196
Drug: Flutamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (250 mg orally, three times a day)
Trial: 31760401
Drug: SLK triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLK triple therapy
Trial: 28229548
Drug: Oligofructose (21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oligofructose (21 g for 12 weeks)
Trial: 26681629
Drug: Nitrate-rich beetroot
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate-rich beetroot juice (525 mg for days 1-3, 1050 mg for day 4)
Trial: 19726379
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg flurbiprofen axetil (group F)
Trial: 19726379
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml intravenous saline (group C)
Trial: 15152708
Drug: Chestnut Health
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chestnut Health System's best‐practice Outpatient Treatment (CHS)
Trial: 15152708
Drug: Cannabis Youth
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabis Youth Treatment (CYT)
Trial: 20664903
Drug: Fluvastatin 80
RxNorm normalized name: fluvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 80 mg daily
Trial: 12473255
Drug: Fluvastatin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin treatment in patients with pronounced ischaemia
Trial: 9726529
Drug: Computer-assisted prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-assisted prescription systems for anticoagulation management
Trial: 8612436
Drug: Animal protein
RxNorm normalized name: Animal protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Animal protein diet (APD) (protein intake 1.1 g · kg‐1 · day‐1)
Trial: 8612436
Drug: Vegetable protein
RxNorm normalized name: Hydrogenated Vegetable Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vegetable protein diet (VPD) (protein intake 0.95 g · kg‐1 · day‐1)
Trial: 2094145
Drug: 3mg PGE2
RxNorm normalized name: dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3mg PGE2 vaginal tablet
Trial: 2094145
Drug: 1mg PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 1mg PGE2 vaginal gel
Trial: 25845223
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus Lipitor (20 mg/tablet, one tablet per day for 6 weeks)
Trial: 25845223
Drug: Lipitor (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipitor (20 mg/tablet, one tablet per day for 6 weeks)
Trial: 22893038
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg isoxsuprine tablets four times per day (Group A, n=15)
Trial: 22893038
Drug: Dexamethasone with
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone with hyaluronidase intralesional injections (Group B, n=15)
Trial: 22893038
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets (Group C, n=10)
Trial: 11641307
Drug: L-arginine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine infusion in group A (n=27)
Trial: 11641307
Drug: L-arginine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine infusion in group B (n=18)
Trial: 11641307
Drug: L-arginine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine infusion in group C (n=11)
Trial: 9855336
Drug: Intravenous estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous estradiol (various dosages)
Trial: 27456983
Drug: Ongoing triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing triple therapy
Trial: 28754491
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human C1 esterase inhibitor twice weekly (50 IU/kg; maximum 4200 IU)
Trial: 28754491
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human C1 esterase inhibitor once weekly (50 IU/kg; maximum 4200 IU)
Trial: 22010226
Drug: Plastic grid
RxNorm normalized name: plastic IUD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plastic grid floor (G)
Trial: 12111923
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of handsearching and MEDLINE searching
Trial: 10195518
Drug: 1% lidocaine
RxNorm normalized name: Icy Hot Max 4%-1% Lidocaine Pain Relief Dry Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% lidocaine (0.1 mL/kg) with 1:200,000 epinephrine (0.5 microg/kg)
Trial: 9585275
Drug: Atropine 0.01
RxNorm normalized name: atropine 0.0194 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 0.01 mg/kg followed by test dose
Trial: 7644960
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy given by a physiotherapist
Trial: 7644960
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care by a general practitioner (information and analgesics)
Trial: 2664882
Drug: Carbamazepine as
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine as a comedication to haloperidol (24 mg haloperidol p.d.)
Trial: 2664882
Drug: Haloperidol alone
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol alone (24 mg haloperidol p.d.)
Trial: 559593
Drug: Chloramphenicol 50
RxNorm normalized name: chloramphenicol 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloramphenicol 50 mg/kg body-weight
Trial: 559593
Drug: Epicillin 1
RxNorm normalized name: ampicillin
DrugBank: Ampicillin (DB00415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epicillin 1 g six hourly
Trial: 25161696
Drug: Panax ginseng
RxNorm normalized name: Panax Ginseng
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panax ginseng (200 mg twice daily for four weeks)
Trial: 20495466
Drug: High-dose, extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose, extended-release mesalamine
Trial: 11796769
Drug: Outreach treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outreach treatment (mean of two sessions a week for 27.3 weeks)
Trial: 9242847
Drug: Outreach treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outreach treatment
Trial: 10518963
Drug: Trivastal 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivastal 50 mg LP (doses increased to 150-250 mg/day)
Trial: 7486602
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of nimodipine (0, 30, 60 mg)
Trial: 7486602
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily doses of nimodipine (up to 150 mg in 12 hours)
Trial: 6797752
Drug: Low-dose propranolol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose propranolol (40 mg every 6 hours)
Trial: 6797752
Drug: High-dose propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose propranolol (160 mg every 6 hours)
Trial: 19491817
Drug: Nootropil (piracetam)
RxNorm normalized name: Other psychostimulants and nootropics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nootropil (piracetam) 100 mg/kg daily for 2 months
Trial: 15346756
Drug: Standard Brånemark
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Brånemark System implants
Trial: 15346756
Drug: TiUnite Mk
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TiUnite Mk III implants
Trial: 9715782
Drug: Lisinopril (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (10, 20, or 40 mg/day)
Trial: 9715782
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) (12.5, 25, or 50 mg/day)
Trial: 8009196
Drug: Casodex 50
RxNorm normalized name: Casodex 50mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex 50 mg p.o. daily for seven to 12 months
Trial: 3066086
Drug: Penbutolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penbutolol (40 mg/day)
Trial: 27364322
Drug: Oral teriflunomide
RxNorm normalized name: Teriflunomide
DrugBank: Teriflunomide (DB08880)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral teriflunomide
Trial: 27364322
Drug: Subcutaneous interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous interferon beta‐1a
Trial: 14609783
Drug: Intravenous phytonadione
RxNorm normalized name: Phytonadione
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous phytonadione (0.5 mg for INR 6-10; 1 mg for INR >10)
Trial: 14609783
Drug: Oral phytonadione
RxNorm normalized name: Phytonadione
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral phytonadione (2.5 mg for INR 6-10; 5 mg for INR >10)